Independent directory Public ClinicalTrials.gov records United States
Clear filters
ClinicalTrials.gov public records Last synced Sep 2, 2026, 4:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 62 matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
Completed Not applicable Interventional Accepts healthy volunteers

Growth and Tolerance of Infants Fed Infant Formulas

NCT01808105
Conditions
Growth and Tolerance
Interventions
Control Formula, Experimental Formula 1, Experimental Formula 2, Human Milk
Other
Lead sponsor
Abbott Nutrition
Industry
Eligibility
Up to 5 Days
Enrollment
424 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2013 – 2014
U.S. locations
23
States / cities
Birmingham, Alabama • Dothan, Alabama • Tucson, Arizona + 19 more
Completed Not applicable Interventional Accepts healthy volunteers

Gastrointestinal Tolerance Evaluation of an Infant Formula

NCT03307122
Conditions
Healthy, Full-term Infants Who Are Formula-fed
Interventions
Routine Infant Formula 1, Routine Infant Formula 2
Other
Lead sponsor
Société des Produits Nestlé (SPN)
Industry
Eligibility
9 Days to 19 Days
Enrollment
79 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2017 – 2018
U.S. locations
8
States / cities
Pensacola, Florida • Louisville, Kentucky • Owensboro, Kentucky + 5 more
Recruiting Not applicable Interventional Accepts healthy volunteers

Investigating Baby Behavior and Family Technology Use Study

NCT05781100
Conditions
Mobile Phone Use, Mother-Infant Interaction, Infant Development, Self-Regulation, Emotion, Self-Regulation
Interventions
Technology Use during Feeding Conditions
Behavioral
Lead sponsor
California Polytechnic State University-San Luis Obispo
Other
Eligibility
Not listed
Enrollment
345 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2023 – 2027
U.S. locations
1
States / cities
San Luis Obispo, California
Terminated Phase 3 Interventional Accepts healthy volunteers

Growth and Tolerance of Healthy Term Infants to a New Infant Formula

NCT01137877
Conditions
Healthy Term Infants
Interventions
Milk based infant formula powder, Investigational Infant Formula #1, Investigational Infant Formula #2, Human Milk
Other
Lead sponsor
Abbott Nutrition
Industry
Eligibility
1 Day to 11 Days
Enrollment
399 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2010
U.S. locations
20
States / cities
Little Rock, Arkansas • Mission Hills, California • Norwich, Connecticut + 17 more
Conditions
Gastrointestinal Tolerance
Interventions
Phase 1- Arm 1 Infant Formula, Phase 2- Arm 2 Infant Formula, Phase 2- Arm 3 Infant Formula
Other
Lead sponsor
Abbott Nutrition
Industry
Eligibility
Up to 30 Days
Enrollment
126 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2015
U.S. locations
6
States / cities
Tucson, Arizona • St. Petersburg, Florida • Asheboro, North Carolina + 3 more
Conditions
Hirschsprung Disease
Interventions
VSL#3, Placebo
Drug
Lead sponsor
University of Michigan
Other
Eligibility
1 Month to 12 Months
Enrollment
62 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2006 – 2010
U.S. locations
2
States / cities
Ann Arbor, Michigan • Buffalo, New York
Conditions
Infections, Human Immunodeficiency Virus and Herpesviridae
Interventions
Dolutegravir 50 mg tablet, Dolutegravir 50 mg oral granules
Drug
Lead sponsor
ViiV Healthcare
Industry
Eligibility
18 Years to 65 Years
Enrollment
20 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2011
U.S. locations
1
States / cities
Austin, Texas
Completed Not applicable Interventional Results available

Role of Glucagon-Like Peptide-1 in Postprandial Hypoglycemia

NCT01162499
Conditions
Postprandial Hypoglycemia
Interventions
Exendin-(9-39), Vehicle
Drug · Other
Lead sponsor
Diva De Leon
Other
Eligibility
6 Months to 18 Years
Enrollment
7 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2010 – 2014
U.S. locations
1
States / cities
Philadelphia, Pennsylvania
Conditions
Cyanotic Congenital Heart Disease
Interventions
Bifidobacterium infantis, Placebo
Dietary Supplement · Other
Lead sponsor
University of California, Davis
Other
Eligibility
Up to 4 Months
Enrollment
12 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009 – 2011
U.S. locations
1
States / cities
Sacramento, California
Completed Phase 3 Interventional Accepts healthy volunteers

Tolerance of Healthy Term Infants Fed Infant Formulas #3

NCT00977964
Conditions
Gastrointestinal Tolerance
Interventions
Experimental milk protein infant formula Process A, Experimental milk protein infant formula Process B, Experimental milk protein infant formula Process C, Experimental milk protein infant formula Process D, Experimental milk protein infant formula Process E, Experimental milk protein infant formula Process F
Other
Lead sponsor
Abbott Nutrition
Industry
Eligibility
Up to 8 Days
Enrollment
270 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2009 – 2010
U.S. locations
15
States / cities
Dothan, Alabama • Plantation, Florida • St. Petersburg, Florida + 12 more
Completed No phase listed Observational Accepts healthy volunteers Results available

Unintentional Overfeeding of Formula Fed Infants

NCT02701868
Conditions
Childhood Obesity, Infant Development
Interventions
Not listed
Lead sponsor
Pennington Biomedical Research Center
Other
Eligibility
18 Years and older
Enrollment
171 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2016 – 2017
U.S. locations
1
States / cities
Baton Rouge, Louisiana
Conditions
Gastrointestinal Tolerance
Interventions
Infant Formula 1, Infant Formula 2
Other
Lead sponsor
Abbott Nutrition
Industry
Eligibility
2 Weeks to 9 Weeks
Enrollment
113 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
1996 – 1997
U.S. locations
7
States / cities
Little Rock, Alaska • Aurora, Colorado • Stone Mountain, Georgia + 4 more
Conditions
GERD in Infants
Interventions
Omeprazole, AR formula
Drug · Other
Lead sponsor
Nationwide Children's Hospital
Other
Eligibility
1 Day to 8 Months
Enrollment
369 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2028
U.S. locations
1
States / cities
Columbus, Ohio
Completed Not applicable Interventional Accepts healthy volunteers

Pre-Pregnancy Weight Loss and Baby Behavior Study

NCT06358729
Conditions
Obesity; Familial, Pregnancy Related, Infant Behavior
Interventions
Typical Nipple, Challenging Nipple
Behavioral
Lead sponsor
University of Michigan
Other
Eligibility
3 Months and older
Enrollment
10 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2025
U.S. locations
1
States / cities
Ann Arbor, Michigan
Completed Not applicable Interventional Accepts healthy volunteers

Tolerance of Infants Fed a Hydrolysate Formula

NCT03628183
Conditions
Gastrointestinal Tolerance
Interventions
Hydrolysate Infant Formula 1, Hydrolysate Infant Formula 2
Other
Lead sponsor
Abbott Nutrition
Industry
Eligibility
Up to 14 Days
Enrollment
51 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2018
U.S. locations
5
States / cities
Tucson, Arizona • Owensboro, Kentucky • Cleveland, Ohio + 2 more
Withdrawn Not applicable Interventional Accepts healthy volunteers

Milk Oriented Microbiota

NCT03222804
Conditions
Microbial Colonization
Interventions
Bifidobacterium
Dietary Supplement
Lead sponsor
University of California, Davis
Other
Eligibility
21 Years to 45 Years · Female only
Healthy volunteers
Accepts healthy volunteers
Timeline
2017
U.S. locations
1
States / cities
Sacramento, California
Completed No phase listed Observational Accepts healthy volunteers Results available

Remote Food Photography Method in Infants

NCT01762631
Conditions
Estimating Infant Food Intake
Interventions
Not listed
Lead sponsor
Pennington Biomedical Research Center
Other
Eligibility
18 Years and older
Enrollment
75 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2012 – 2014
U.S. locations
1
States / cities
Baton Rouge, Louisiana
Completed Not applicable Interventional Accepts healthy volunteers

Feeding Tolerance Evaluation

NCT02405572
Conditions
Healthy
Interventions
infant formula
Other
Lead sponsor
Société des Produits Nestlé (SPN)
Industry
Eligibility
Up to 2 Months
Enrollment
43 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
Started 2015
U.S. locations
2
States / cities
Owensboro, Kentucky • Layton, Utah
Conditions
Gastrointestinal Complication, Intestinal Obstruction, Gastroschisis, Hirschsprung Disease, Omphalocele, Midgut Volvulus
Interventions
Standard of Care, Exclusive Human Milk
Dietary Supplement
Lead sponsor
Seattle Children's Hospital
Other
Eligibility
0 Days to 55 Years
Enrollment
116 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2027
U.S. locations
1
States / cities
Seattle, Washington
Completed Not applicable Interventional Accepts healthy volunteers

The Evaluation of Cow's Milk Formula - Study B

NCT00712608
Conditions
Healthy Term Infants
Interventions
Infant formula, Cow's milk infant formula
Other
Lead sponsor
Mead Johnson Nutrition
Industry
Eligibility
12 Days to 16 Days
Enrollment
399 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2008 – 2009
U.S. locations
22
States / cities
Birmingham, Alabama • Dothan, Alabama • Benton, Arkansas + 17 more
Conditions
Diabetes Mellitus, Type 1
Interventions
Hydrolysed infant formula, Nonhydrolysed infant formula
Dietary Supplement
Lead sponsor
University of Helsinki
Other
Eligibility
Up to 7 Days
Enrollment
5,156 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2002 – 2017
U.S. locations
2
States / cities
Tampa, Florida • Pittsburgh, Pennsylvania
Conditions
Breastfeeding, Feeding Behavior
Interventions
EpxBreastfeeding, Baby book survey
Other
Lead sponsor
Washington University School of Medicine
Other
Eligibility
18 Years to 40 Years · Female only
Enrollment
218 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2017 – 2018
U.S. locations
1
States / cities
St Louis, Missouri
Conditions
Type 1 Diabetes Mellitus
Interventions
DHA Treatment, Placebo for DHA
Dietary Supplement
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Eligibility
Up to 5 Months
Enrollment
99 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2006 – 2013
U.S. locations
9
States / cities
Los Angeles, California • Orange, California • San Francisco, California + 6 more
Conditions
Gastrointestinal Tolerance
Interventions
Experimental Infant Formula 1, Experimental Infant Formula 2, Experimental Infant Formula 3, Active Comparator: Control Infant Formula
Other
Lead sponsor
Abbott Nutrition
Industry
Eligibility
2 Weeks to 9 Weeks
Enrollment
115 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
1992 – 1994
U.S. locations
7
States / cities
Little Rock, Arkansas • Aurora, Illinois • Owensboro, Kentucky + 4 more